Question 1

Does Connor, Clark & Lunn Investment Management own VIVO stock?

Accepted Answer

No. Connor, Clark & Lunn Investment Management exited its VIVO (Meridian Bioscience) position in Q3 2020. Its Q2 2020 13F listed 15,571 shares worth $363,000.

Question 2

How many shares of VIVO does Connor, Clark & Lunn Investment Management own?

Accepted Answer

None since Q3 2020, when Connor, Clark & Lunn Investment Management exited the position. Its Q2 2020 13F listed 15,571 shares worth $363,000.

Question 3

What is Connor, Clark & Lunn Investment Management's VIVO position worth?

Accepted Answer

Connor, Clark & Lunn Investment Management's VIVO position was worth $363,000 in its Q2 2020 13F, before the exit in Q3 2020.

Question 4

Is Connor, Clark & Lunn Investment Management buying or selling VIVO?

Accepted Answer

In Q3 2020, Connor, Clark & Lunn Investment Management exited its entire VIVO position.

Question 5

When did Connor, Clark & Lunn Investment Management first buy VIVO?

Accepted Answer

Connor, Clark & Lunn Investment Management already held VIVO in its Q4 2018 13F, the earliest on record, and listed it in 6 quarterly 13F filings.